AstraZeneca Warns Of Higher Costs As Drug Sales Slide

02.08.2013 - British drugmaker AstraZeneca warned on Thursday of higher costs in 2013 as it invests through a slump in sales caused by a wave of patent expiries on key medicines. The prediction...